In Vivo Measurement of Dopamine Receptors in Human Brain by Positron Emission Tomography Age and Sex Differences a

[1]  C. Finch,et al.  Dopaminergic Changes in the Basal Ganglia A Generalized Phenomenon of Aging in Mammals a , 1988, Annals of the New York Academy of Sciences.

[2]  C. Finch,et al.  Dopamine and Serotonin Systems in Human and Rodent Brain: Effects of Age and Neurodegenerative Disease , 1987, Journal of the American Geriatrics Society.

[3]  G. Pearlson,et al.  Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics. , 1986, Science.

[4]  J. Joyce,et al.  Age-related regional loss of caudate-putamen dopamine receptors revealed by quantitative autoradiography , 1986, Brain Research.

[5]  J. Links,et al.  Response: human brain receptor distribution. , 1986, Science.

[6]  J M Links,et al.  Quantification of Neuroreceptors in the Living Human Brain. II. Inhibition Studies of Receptor Density and Affinity , 1986, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[7]  A. Gjedde,et al.  Quantification of Neuroreceptors in the Living Human Brain. I. Irreversible Binding of Ligands , 1986, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[8]  J. Joyce,et al.  Effects of estrogen on the basal ganglia , 1986, Neuroscience & Biobehavioral Reviews.

[9]  S. Stahl,et al.  Neurochemistry of dopamine in Huntington's dementia and normal aging. , 1986, Archives of general psychiatry.

[10]  T. Paolo,et al.  Modulation of brain and pituitary dopamine receptors by estrogens and prolactin , 1985, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[11]  L. M. Brenner,et al.  Estrogen replacement and tardive dyskinesia , 1985, Psychoneuroendocrinology.

[12]  G. Breese,et al.  Evidence that D-1 dopamine receptors contribute to the supersensitive behavioral responses induced by L-dihydroxyphenylalanine in rats treated neonatally with 6-hydroxydopamine. , 1985, The Journal of pharmacology and experimental therapeutics.

[13]  P. Randall,et al.  D-2 dopamine receptors in aging mouse striatum: determination of high- and low-affinity agonist binding sites. , 1985, The Journal of pharmacology and experimental therapeutics.

[14]  S. G. Burchinsky.  Neurotransmitter receptors in the central nervous system and aging: Pharmacological aspect (review) , 1984, Experimental Gerontology.

[15]  M. Folstein,et al.  EFFECTS OF AGE ON DOPAMINE AND SEROTONIN RECEPTORS MEASURED BY POSITRON TOMOGRAPHY IN THE LIVING HUMAN BRAIN , 1984, Science.

[16]  J. Waddington,et al.  Loss of rat striatal dopamine receptors with ageing is selective for D-2 but not D-1 sites: association with increased non-specific binding of the D-1 ligand [3H]piflutixol. , 1984, European journal of pharmacology.

[17]  G. Breese,et al.  Neonatal-6-hydroxydopamine treatment: Model of susceptibility for self-mutilation in the lesch-nyhan syndrome , 1984, Pharmacology Biochemistry and Behavior.

[18]  G. Breese,et al.  Comparison of the CNS effects induced by TRH and bicuculline after microinjection into medial septum, substantia nigra and inferior colliculus: Absence of support for a GABA antagonist action for TRH , 1984, Pharmacology Biochemistry and Behavior.

[19]  J. Links,et al.  Imaging dopamine receptors in the human brain by positron tomography. , 1984, Science.

[20]  J. A. Severson.  Neurotransmitter Receptors and Aging , 1984, Journal of the American Geriatrics Society.

[21]  Jonathan M. Links,et al.  Imaging dopamine receptors in the human brain by positron tomography , 1983 .

[22]  P. Piccardi,et al.  Effect of estrogens on dopamine autoreceptors in male rats. , 1983, European journal of pharmacology.

[23]  J. Gordon,et al.  Pre- and postsynaptic neurochemical alterations following estrogen-induced striatal dopamine hypo- and hypersensitivity , 1983, Brain Research Bulletin.

[24]  P. Poyet,et al.  Prolactin and estradiol increase striatal dopamine receptor density in intact, castrated and hypophysectomized rats , 1982, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[25]  J. Marcusson,et al.  Age‐Correlated Loss of Dopaminergic Binding Sites in Human Basal Ganglia , 1982, Journal of neurochemistry.

[26]  G. Roth,et al.  Changes in the mechanisms of hormone and neurotransmitter action during aging: Current status of the role of receptor and post-receptor alterations. A review , 1982, Mechanisms of Ageing and Development.

[27]  M. Wilson,et al.  Age alters dopaminergic responses to estradiol. , 1982, European journal of pharmacology.

[28]  M. Heiman,et al.  Dopaminergic receptors in the rat anterior pituitary change during the estrous cycle. , 1982, Endocrinology.

[29]  J. Joyce,et al.  Estradiol suppresses then enhances intracaudate dopamine-induced contralateral deviation. , 1982, European journal of pharmacology.

[30]  K. Pitman,et al.  Effects of estrogen on striatal dopamine receptor function in male and female rats , 1982, Pharmacology Biochemistry and Behavior.

[31]  J. Fields,et al.  Estrogen inhibits the dopaminergic supersensitivity induced by neuroleptics. , 1982, Life sciences.

[32]  J. Joseph,et al.  Development of dopamine receptor denervation supersensitivity in the neostriatum of the senescent rat. , 1981, Life sciences.

[33]  M. Memo,et al.  Aging process affects a single class of dopamine receptors , 1980, Brain Research.

[34]  H. Shelat,et al.  Effect of age on adrenergic and dopaminergic receptor binding in rat brain. , 1980, Life sciences.

[35]  L. Thal,et al.  Evidence for loss of brain [3H]spiroperidol and [3H]ADTN binding sites in rabbit brain with aging , 1980, Brain Research.

[36]  C. Finch,et al.  Reduced dopaminergic binding during aging in the rodent striatum , 1980, Brain Research.

[37]  S. Pradhan.  Central neurotransmitters and aging. , 1980, Life sciences.

[38]  S. Bentin,et al.  Reduction in Regional Cerebral Blood Flow During Normal Aging in Man , 1980, Stroke.

[39]  F. Labrie,et al.  Effects of estrogens on the characteristics of [3H]spiroperidol and [3H]RU24213 binding in rat anterior pituitary gland and brain , 1979, Molecular and Cellular Endocrinology.

[40]  J. Leysen,et al.  Spiperone: a ligand of choice for neuroleptic receptors. 2. Regional distribution and in vivo displacement of neuroleptic drugs. , 1978, Biochemical pharmacology.

[41]  M. Baudry,et al.  In vivo binding of 3H-pimozide in mouse striatum: effects of dopamine agonists and antagonists. , 1977, Life sciences.

[42]  A. Herz,et al.  The demonstration in vivo of specific binding sites for neuroleptic drugs in mouse brain , 1977, Brain Research.

[43]  I. Feinberg,et al.  RELATION OF EEG TO CEREBRAL BLOOD FLOW AND METABOLISM IN OLD AGE. , 1963, Electroencephalography and clinical neurophysiology.

[44]  I. Feinberg,et al.  Bilateral studies of cerebral oxygen uptake in young and aged normal subjects and in patients with organic dementia. , 1960, The Journal of clinical investigation.

[45]  S. Kety.  Human cerebral blood flow and oxygen consumption as related to aging. , 1956, Research publications - Association for Research in Nervous and Mental Disease.

[46]  F. Courtice.  THE METABOLISM OF THE BRAIN , 1940, Journal of neurology and psychiatry.

[47]  E. London.  Metabolism of the Brain a Measure of Cellular Function in Aging , 1984 .

[48]  M. Kuhar,et al.  Dopamine receptor binding in vivo: the feasibility of autoradiographic studies. , 1978, Life sciences.